Literature DB >> 11425010

Allelic variants of the alpha1a adrenoceptor and the promoter region of the alpha2a adrenoceptor and temperament factors.

S J Tsai1, Y C Wang, C J Hong.   

Abstract

Human personality traits are partially determined by genes. It has been suggested that the reward-dependence dimension assessed by the Tridimensional Personality Questionnaire (TPQ) is related to the central noradrenergic system. Our population-based association study tested the hypothesis that genetic variants of the adrenoceptor are associated with this personality trait. The alpha1a- and the alpha2a-adrenoceptor genotypes were determined for 198 healthy Han Chinese who had completed the TPQ. We found no significant differences for TPQ personality-factor scores, including reward dependence and its subscales, for subjects showing different adrenoceptor genotypes. Our negative findings suggest that polymorphisms of the alpha1a adrenoceptor and of the promoter region of the alpha2a-adrenoceptor have no major effect on the reward-dependence personality trait as assessed by TPQ.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11425010

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

1.  Haplotype block and superblock structures of the alpha1-adrenergic receptor genes reveal echoes from the chromosomal past.

Authors:  B Buzas; I Belfer; H Hipp; I Lorincz; C Evans; G Phillips; J Taubman; M B Max; D Goldman
Journal:  Mol Genet Genomics       Date:  2004-10-16       Impact factor: 3.291

2.  The role of the ADRA2A C1291G genetic polymorphism in response to dexmedetomidine on patients undergoing coronary artery surgery.

Authors:  Seyhan Yağar; Soner Yavaş; Bensu Karahalil
Journal:  Mol Biol Rep       Date:  2010-11-23       Impact factor: 2.316

3.  Relationship among methadone dose, polymorphisms of dopamine D2 receptor and tri-dimensional personality questionnaire in heroin-addicted patients.

Authors:  Min-Wei Huang; Tai-An Chiang; Pei-Yu Lo; Ching-Shan Huang
Journal:  Behav Brain Funct       Date:  2016-08-31       Impact factor: 3.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.